Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice

Fig. 3

Analysis of tumor growth dynamics between the reference and experimental periods in patients in this cohort. Pairwise comparisons of log-transformed TGR (a) and TGKR (b) between the reference time and experimental periods. Red color; HPD, Orange color; PD with accelerated TGKR but without HPD, Blue color; PD with decelerated TGR or TGKR, Light Blue color; SD with decelerated TGR or TGKR

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us